Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To obtain a better understanding on the comparative effectiveness of dabigatran versus
Vitamin K antagonist (VKA) for stroke prevention in patients with Non-valvular atrial
fibrillation (NVAF) in a real-life setting.